Biolase

BIOL50

High Value

$0.060.00%$0.00

High Value

Penny Stock

BIOL50

$0.06

0.00%$0.00

High Value

Penny Stock

Performance History

Key Stats
Open	$0.05
Prev. Close	$0.06
EPS	16.18
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$2.19M

	LOW	HIGH
Day Range	0.05	0.06
52 Week Range	0.04	4.10

Ratios

Revenue	-





EPS	16.18

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Biolase (BIOL)

Biolase Inc (BIOL) is a medical device company that specializes in laser systems for dental and other medical applications. The company's flagship product is the Waterlase system, which uses water-energized laser technology to perform a wide range of dental procedures with less pain and faster healing times. The Waterlase system has been widely adopted by dental professionals worldwide and has received numerous awards for its innovative design and clinical effectiveness. In addition to its dental products, Biolase also offers laser systems for medical and aesthetic applications, such as skin rejuvenation and hair removal.

Biolase Inc has a market cap of $XX billion and is listed on the Nasdaq exchange under the ticker symbol BIOL. The company's stock price has experienced significant volatility in recent years, with highs and lows influenced by factors such as financial performance, regulatory developments, and industry trends. As of the most recent trading day, Biolase Inc's stock price was $XX, with a 52-week range of $XX to $XX. The stock's average daily trading volume is $XX shares.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. John R. Beaver
Headquarters: Foothill Ranch
Employees: 188
Exchange: NASDAQ

Keep an eye on Biolase

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Biolase 's (BIOL) price per share?

The current price per share for Biolase (BIOL) is $0.06. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Biolase (BIOL)?

For Biolase (BIOL), the 52-week high is $4.1, which is 6.73K% from the current price. The 52-week low is $0.04, the current price is 50% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Biolase (BIOL) a growth stock?

Biolase (BIOL) has shown an average price growth of 0.41% over the past three years. It has received a score of -6 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Biolase as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Biolase (BIOL) stock price performance year to date (YTD)?

As of the latest data, Biolase (BIOL) has a year-to-date price change of -94.55%. Over the past month, the stock has experienced a price change of -9.09%. Over the last three months, the change has been -59.97%. Over the past six months, the figure is -57.45%. Looking at a longer horizon, the five-year price change stands at -100%.

help

Is Biolase (BIOL) a profitable company?

Biolase (BIOL) has a net income of -$20.63M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 34.02% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -27.87% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 1.45%, providing insight into the company's sales performance and growth. The gross profit is $16.72M. Operating income is noted at -$17.94M. Furthermore, the EBITDA is -$13.18M.

help

What is the market capitalization of Biolase (BIOL)?

Biolase (BIOL) has a market capitalization of $2.2M. The average daily trading volume is 98.34K, indicating the stock's liquidity and investor engagement.